Drug Profile
JNJ 64991524
Alternative Names: JNJ-64991524Latest Information Update: 28 Dec 2020
Price :
$50
*
At a glance
- Originator Janssen Research & Development
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Dec 2020 No recent reports of development identified for phase-I development in Unspecified(In volunteers) in Belgium (PO, Capsule)